Advisory Services Network’s Outlook Therapeutics OTLK Stock Holding History

Advisory Services Network’s Portfolio OTLK Stock Details OTLK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-303	Closed	-$15K	–	2658
2021 Q2	$15K	Buy	+303	New	+$14.1K	﹤0.01%	2628
2018 Q2	–	Sell	-13	Closed	-$2K	–	2631
2018 Q1	$2K	Hold	13	–	–	﹤0.01%	2392
2017 Q4	$3K	Hold	13	–	–	﹤0.01%	2283
2017 Q3	$3K	Hold	13	–	–	﹤0.01%	2070
2017 Q2	$2K	Buy	+13	New	+$3.67K	﹤0.01%	2125

Other funds holding OTLK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LVW Advisors Pittsford, New York $1.16B AUM 26.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advisory Services Network's OTLK Position: Q3 2021 in Review

Advisory Services Network sold out of Outlook Therapeutics (OTLK) in Q3 2021, closing a stake of 303 shares — an estimated $15K sold.

Advisory Services Network first reported a position in OTLK in Q2 2017 and held it in 5 quarters. The position peaked at $15K in Q2 2021. 63 funds tracked by Wall St. Rank hold OTLK as of Q3 2021.

Advisory Services Network reported no remaining Outlook Therapeutics position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 303 Outlook Therapeutics shares in Q3 2021, an estimated $15K.
Advisory Services Network first reported a position in Outlook Therapeutics in Q2 2017 and held it in 5 quarters.
Advisory Services Network's Outlook Therapeutics position peaked at $15K in Q2 2021.
63 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.